Could a simple dye replace major surgery for ovarian cancer staging?
NCT ID NCT07508306
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a blue dye injected into the ovary can help doctors find the first lymph node where cancer might spread, instead of removing many lymph nodes. The goal is to see if this less invasive method works as well as standard surgery for early-stage ovarian cancer. About 30 women with stage I or II ovarian cancer will take part. If successful, this approach could reduce side effects like pain and longer recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY STAGE OVARIAN TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maternity and neonatology center of Tunis
RECRUITINGLa Rabta, 1007, Tunisia
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple paper tool help melanoma patients make tough biopsy decisions?
- Could a simpler surgery be safer for aggressive uterine cancer?
- Green dye could replace extra incisions in breast cancer surgery
- Green dye could replace radioactive tracers in breast cancer surgery
- New breast cancer surgery could spare women from unnecessary lymph node removal
- Could a simpler biopsy replace major surgery for inflammatory breast cancer?